BarkerRW. Accelerating translational research processes from bench to clinic. Rejuvenation Res, 2013; 16(Suppl 1):S14.
10.
RussellA. The disruptive potential of tissue engineering. Rejuvenation Res, 2013; 16(suppl 1):S37.
11.
ItoF, MoriT, KikkawaK, OkadaH. Approach to assessing the walking motion of elderly males based on kinetic parameters of young males. Rejuvenation Res, 2012; 15:198–200.
AttarA, RahimiF, BitanG. Modulators of amyloid protein aggregation and toxicity: EGCG and CLR01. Translat Neurosci, 2013; 4:385–409.
14.
FunkeSA, LiuH, SehlT, BartnikD, BrenerO, Nagel-StegerL, WiesehanK, WillboldD. Identification and characterization of an aβ oligomer precipitating peptide that may be useful to explore gene therapeutic approaches to Alzheimer disease. Rejuvenation Res, 2012; 15:144–147.
15.
BahrBA, WisniewskiML, ButlerD. Positive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseases. Rejuvenation Res, 2012; 15:189–197.
16.
MendelsohnAR, LarrickJW. Rejuvenation of adult stem cells: Is age-associated dysfunction epigenetic?. Rejuvenation Res, 2013; 16:152–157.
Font de MoraJ, Díez JuanA. The decay of stem cell nourishment at the niche. Rejuvenation Res, 2013; 16:487–494.
20.
Almeida-PoradaG, SolandM, BouraJ, MokhtariS, PoradaC. Engineering stem cells for liver and gut regeneration. Rejuvenation Res, 2013; 16(Suppl 1):S12.
21.
SmitheyMJ, LiG, VenturiV, DavenportMP, Nikolich-ZugichJ. Life-long persistent viral infection alters the naïve T-cell pool, impairing CD8 T-cell immunity in late life. Rejuvenation Res, 2013; 16(Suppl 1):S40.
22.
FormigaF, FerrerA, AlburquerqueJ, Fernández-QuevedoM, RoyoC, PujolR; Octabaix Study Members. The challenge of maintaining successful aging at 87 years old: The Octabaix study two-year follow-up. Rejuvenation Res, 2012; 15:584–589.
